• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑制 PDE-4 同工酶可减弱激动剂诱导的输尿管相收缩的频率和整体收缩性。

Inhibition of PDE-4 isoenzyme attenuates frequency and overall contractility of agonist-evoked ureteral phasic contractions.

机构信息

Centre for Urology, Faculty of Health Sciences & Medicine, Bond University, Gold Coast, Queensland, Australia.

Department of Cell Physiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

出版信息

Pharmacol Res Perspect. 2024 Feb;12(1):e1175. doi: 10.1002/prp2.1175.

DOI:10.1002/prp2.1175
PMID:38339883
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10858371/
Abstract

The aim of this study was to investigate the functional role of phosphodiesterase enzymes (PDE) in the isolated porcine ureter. Distal ureteral strips were mounted in organ baths and pre-contracted with 5-HT (100 μM). Upon generation of stable phasic contractions, PDE-4 and PDE-5 inhibitors were added cumulatively to separate tissues. PDE-4 inhibitors, such as rolipram (10 nM and greater) and roflumilast (100 nM and greater), resulted in significant attenuation of ureteral contractile responses, while a higher concentration of piclamilast (1 μM and greater) was required to induce a significant depressant effect. The attenuation effect by rolipram was abolished by SQ22536 (100 μM). PDE-5 inhibitors, such as sildenafil and tadalafil, were not nearly as effective and were only able to suppress the 5-HT-induced contractions at higher concentrations of 1 μM. Rolipram significantly enhanced the depressant effect of forskolin, while sodium nitroprusside-induced attenuation of contractile responses remained unchanged in the presence of tadalafil. In summary, our study demonstrates that PDE-4 inhibitors are effective in attenuating 5-HT-induced contractility in porcine distal ureteral tissues, while PDE-5 inhibitors are less effective. These findings suggest that PDE-4 inhibitors, such as rolipram, may hold promise as potential therapeutic agents for the treatment of ureteral disorders attributable to increased intra-ureteral pressure.

摘要

本研究旨在探讨磷酸二酯酶(PDE)在猪离体输尿管中的功能作用。将远端输尿管条段置于器官浴中,并以 5-HT(100μM)预收缩。当产生稳定的阶段性收缩时,以累积方式向分离的组织中添加 PDE-4 和 PDE-5 抑制剂。PDE-4 抑制剂,如罗利普兰(10nM 及以上)和罗氟司特(100nM 及以上),可显著抑制输尿管收缩反应,而需要更高浓度的匹立米隆(1μM 及以上)才能产生显著的抑制作用。SQ22536(100μM)可消除罗利普兰的抑制作用。PDE-5 抑制剂,如西地那非和他达拉非,效果则不那么显著,仅能在更高浓度 1μM 时抑制 5-HT 诱导的收缩。罗利普兰显著增强了 forskolin 的抑制作用,而在存在他达拉非的情况下,硝普钠诱导的收缩反应抑制作用保持不变。总之,我们的研究表明,PDE-4 抑制剂可有效抑制猪远端输尿管组织中 5-HT 诱导的收缩,而 PDE-5 抑制剂效果则较差。这些发现表明,PDE-4 抑制剂,如罗利普兰,可能作为治疗因输尿管内压升高引起的输尿管疾病的潜在治疗剂具有应用前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05fa/10858371/649769fe7260/PRP2-12-e1175-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05fa/10858371/c17710e779b8/PRP2-12-e1175-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05fa/10858371/10cbba583f66/PRP2-12-e1175-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05fa/10858371/84b5b48e625e/PRP2-12-e1175-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05fa/10858371/b185e5ceb2d7/PRP2-12-e1175-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05fa/10858371/0ff00fec6a7c/PRP2-12-e1175-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05fa/10858371/a7dbf096927d/PRP2-12-e1175-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05fa/10858371/649769fe7260/PRP2-12-e1175-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05fa/10858371/c17710e779b8/PRP2-12-e1175-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05fa/10858371/10cbba583f66/PRP2-12-e1175-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05fa/10858371/84b5b48e625e/PRP2-12-e1175-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05fa/10858371/b185e5ceb2d7/PRP2-12-e1175-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05fa/10858371/0ff00fec6a7c/PRP2-12-e1175-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05fa/10858371/a7dbf096927d/PRP2-12-e1175-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05fa/10858371/649769fe7260/PRP2-12-e1175-g003.jpg

相似文献

1
Inhibition of PDE-4 isoenzyme attenuates frequency and overall contractility of agonist-evoked ureteral phasic contractions.抑制 PDE-4 同工酶可减弱激动剂诱导的输尿管相收缩的频率和整体收缩性。
Pharmacol Res Perspect. 2024 Feb;12(1):e1175. doi: 10.1002/prp2.1175.
2
Phosphodiesterase isoenzymes in the human urethra: a molecular biology and functional study.人类尿道中的磷酸二酯酶同工酶:一项分子生物学与功能研究。
Eur J Pharmacol. 2014 Oct 15;741:330-5. doi: 10.1016/j.ejphar.2014.08.005. Epub 2014 Aug 23.
3
Phosphodiesterase isoenzymes in human ureteral smooth muscle: identification, characterization, and functional effects of various phosphodiesterase inhibitors in vitro.人输尿管平滑肌中的磷酸二酯酶同工酶:体外各种磷酸二酯酶抑制剂的鉴定、表征及功能效应
Urol Int. 1995;55(4):183-9. doi: 10.1159/000282783.
4
Powerful relaxation of phosphodiesterase type 4 inhibitor rolipram in the pig and human bladder neck.磷酸二酯酶 4 抑制剂罗利普兰对猪和人膀胱颈的强力松弛作用。
J Sex Med. 2014 Apr;11(4):930-941. doi: 10.1111/jsm.12456. Epub 2014 Feb 12.
5
Effects of rolipram and roflumilast, phosphodiesterase-4 inhibitors, on hypertension-induced defects in memory function in rats.罗利普兰和罗氟司特,磷酸二酯酶-4 抑制剂,对高血压诱导的大鼠记忆功能缺陷的影响。
Eur J Pharmacol. 2015 Jan 5;746:138-47. doi: 10.1016/j.ejphar.2014.10.039. Epub 2014 Nov 6.
6
PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries.磷酸二酯酶4和磷酸二酯酶5调节环核苷酸对人脐动脉的舒张作用。
Eur J Pharmacol. 2008 Mar 17;582(1-3):102-9. doi: 10.1016/j.ejphar.2007.12.017. Epub 2007 Dec 28.
7
Characterization of cyclic nucleotide phosphodiesterase isoenzymes in the human ureter and their functional role in vitro.人输尿管中环核苷酸磷酸二酯酶同工酶的特性及其体外功能作用
World J Urol. 1994;12(5):286-91. doi: 10.1007/BF00191209.
8
Effects of phosphodiesterase inhibitors on the contractile responses of isolated human seminal vesicle tissue to adrenergic stimulation.磷酸二酯酶抑制剂对离体人精囊组织对肾上腺素能刺激的收缩反应的影响。
J Sex Med. 2009 Feb;6(2):408-14. doi: 10.1111/j.1743-6109.2008.01085.x. Epub 2008 Nov 17.
9
Relaxation of phasic contractile activity of human detrusor strips by cyclic nucleotide phosphodiesterase type 4 inhibition.通过抑制4型环核苷酸磷酸二酯酶来舒张人逼尿肌条的相性收缩活动
Eur Urol. 2007 Mar;51(3):772-80; discussion 780-1. doi: 10.1016/j.eururo.2006.10.023. Epub 2006 Oct 25.
10
Relaxation of human ureteral smooth muscle in vitro by modulation of cyclic nucleotide-dependent pathways.通过调节环核苷酸依赖性途径使体外培养的人输尿管平滑肌松弛。
Urol Res. 2000 Apr;28(2):110-5. doi: 10.1007/s002400050147.

引用本文的文献

1
Drugs to affect the smooth musculature of the human ureter - an update with integrated information from basic science to the use in medical expulsion therapy (MET).影响人类输尿管平滑肌的药物——从基础科学到在医学排出疗法(MET)中的应用的综合信息更新。
World J Urol. 2024 Nov 28;42(1):654. doi: 10.1007/s00345-024-05368-5.

本文引用的文献

1
The Concise Guide to PHARMACOLOGY 2023/24: Enzymes.《药理学简明指南 2023/24:酶》
Br J Pharmacol. 2023 Oct;180 Suppl 2:S289-S373. doi: 10.1111/bph.16181.
2
Mirabegron attenuates porcine ureteral contractility via α1-adrenoceptor antagonism.米拉贝隆通过拮抗α1-肾上腺素能受体来减轻猪输尿管的收缩性。
Naunyn Schmiedebergs Arch Pharmacol. 2022 Jul;395(7):839-847. doi: 10.1007/s00210-022-02244-0. Epub 2022 Apr 21.
3
A Review on Phosphodiesterase-5 Inhibitors as a Topical Therapy for Erectile Dysfunction.磷酸二酯酶-5 抑制剂作为治疗勃起功能障碍的局部治疗方法的综述。
Sex Med Rev. 2022 Jul;10(3):376-391. doi: 10.1016/j.sxmr.2022.02.002. Epub 2022 Apr 1.
4
Mechanosensitive modulation of peristaltic contractions in the mouse renal pelvis.机械敏感性调节小鼠肾盂蠕动收缩。
Eur J Pharmacol. 2022 Apr 5;920:174834. doi: 10.1016/j.ejphar.2022.174834. Epub 2022 Feb 17.
5
Blame the signaling: Role of cAMP for the resolution of inflammation.归咎于信号:cAMP 在炎症消退中的作用。
Pharmacol Res. 2020 Sep;159:105030. doi: 10.1016/j.phrs.2020.105030. Epub 2020 Jun 17.
6
Efficacy of Tamsulosin plus Tadalafil versus Tamsulosin as Medical Expulsive Therapy for Lower Ureteric Stones: A Randomized Controlled Trial.坦索罗辛联合他达拉非与坦索罗辛作为输尿管下段结石药物排石疗法的疗效:一项随机对照试验
Adv Urol. 2020 Jan 29;2020:4347598. doi: 10.1155/2020/4347598. eCollection 2020.
7
Phosphodiesterase-4 inhibitors for chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病的磷酸二酯酶-4抑制剂
Cochrane Database Syst Rev. 2020 May 1;5(5):CD002309. doi: 10.1002/14651858.CD002309.pub6.
8
Kidney stone disease: an update on its management in primary care.肾结石病:基层医疗中其管理的最新进展。
Br J Gen Pract. 2020 Mar 26;70(693):205-206. doi: 10.3399/bjgp20X709277. Print 2020 Apr.
9
Local delivery of vasodilators for the reduction of ureteral contractions: limited but promising.局部递送血管扩张剂以减少输尿管收缩:作用有限但前景可期。
World J Urol. 2021 Jan;39(1):289-290. doi: 10.1007/s00345-020-03113-2. Epub 2020 Feb 7.
10
Phosphodiesterase 5 inhibitors for pulmonary hypertension.用于治疗肺动脉高压的磷酸二酯酶5抑制剂。
Cochrane Database Syst Rev. 2019 Jan 31;1(1):CD012621. doi: 10.1002/14651858.CD012621.pub2.